ARCHIVES

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

This article is from The Cancer Letter archive.

Vol. 32 No. 42 | November 22, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Bresnick Directs Norris Cotton Cancer Center; FASEB Honors Kirschstein; Van Nevel’s 2th Year

February 5, 1993

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

Sen. Edward Kennedy Receives ACS Medal

January 23, 2009

Letters: Broder Response To Waxman Called Political Back-Pedaling

February 11, 1994

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

New Surgery Grant Applications To Be Reviews By Special Ad Hoc Study Section; 54 Submitted

June 22, 1979